Study design
DIABETIC DYSLIPIDEMIA
In this study, we performed a controlled clinical trial, single-blinding, randomized, prospective, and pre–post-intervention study to assess 8 weeks of combined training and 500 mg propolis supplement consumption in women with Diabetic dyslipidemia [Dietary intakeOn the other hand, we predicted binding affinity numerate between effective bioactive compounds of propolis on the cut-point proteins in the PPIs network by molecular docking method. In this study, all protocols were completed in compliance with the Islamic Azad University Isfahan (Khorasgan) branch research ethics committee (IR.IAU.KHUISF.REC.1400.265). Furthermore, this study was registered in the Iranian Registry of Clinical Trials; IRCT code: IRCT20211229053561N1.